Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 828-834

  Hattori, Yoshiyuki ^a   Kawakami, Shigeru ^a   Nakamura, Kazumi ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPLEX; LIPOSOME; LUCIFERASE; MANNOSE; MANNOSE RECEPTOR; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO CULTURE; LIVER; MACROPHAGE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; SPLEEN;

ANALGESICS, NON-NARCOTIC; ANIMALS; CELLS, CULTURED; CLODRONIC ACID; DENDRITIC CELLS; DNA; EXCIPIENTS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; INJECTIONS, INTRAPERITONEAL; LIPOSOMES; LUCIFERASES; MACROPHAGES; MACROPHAGES, PERITONEAL; MANNOSE; MICE; MICE, INBRED ICR; RNA, MESSENGER; TRANSFECTION;

EID: 33745942504     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105098     Document Type: Article

References (37)

1. Akbari O, Panjwani N, Garcia S, Tascon R, Lowrie D, and Stockinger B (1999) DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med 189:169-178.
2. Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, Dubinett S, Glaspy J, McBride WH, and Economou JS (1997) A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 4:17-25.
3. Biewenga J, van der Ende MB, Krist LF, Borst A, Ghufron M, and Van Rooijen N (1995) Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res 280:189-196.
4. Cano A, Fragoso G, Gevorkian G, Terrazas LI, Petrossian P, Govezensky T, Sciutto E, and Manoutcharian K (2001) Intraspleen DNA inoculation elicits protective cellular immune responses. DNA Cell Biol 20:215-221.
5. Dufes C, Uchegbu IF, and Schatzlein AG (2005) Dendrimers in gene delivery. Adv Drug Deliv Rev 57:2177-2202.
6. Fellowes R, Etheridge CJ, Coade S, Cooper RG, Stewart L, Miller AD, and Woo P (2000) Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther 7:967-977.
7. Fumoto S, Kawakami S, Shigeta K, Higuchi Y, Yamashita F, and Hashida M (2005) Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex. J Pharmacol Exp Ther 315:484-493.
8. Gelderblom H, Verweij J, van Zomeren DM, Buijs D, Ouwens L, Nooter K, Stoter G, and Sparreboom A (2000) Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel. Clin Cancer Res 8:1237-1241.
9. Hashida M, Kawakami S, and Yamashita F (2005) Lipid carrier systems for targeted drug and gene delivery. Chem Pharm Bull 53:871-880.
10. Hattori Y, Kawakami S, Suzuki S, Yamashita F, and Hashida M (2004) Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem Biophys Res Commun 317:992-999.
11. Hattori Y, Kawakami S, Yan L, Nakamura K, Yamashita F, and Hashida M (2006) Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration. J Gene Med 8:824-834.
12. Hattori Y, Suzuki S, Kawakami S, Yamashita F, and Hashida M (2005) The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J Control Release 108:484-495.
13. Hepp KD (1994) Implantable insulin pumps and metabolic control. Diabetologia 37:S108-S111.
14. Ishii N, Fukushima J, Kaneko T, Okada E, Tani K, Tanaka SI, Hamajima K, Xin KQ, Kawamoto S, Koff W, et al. (1997) Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 13:1421-1428.
15. Kawakami S, Ito Y, Fumoto S, Yamashita F, and Hashida M (2005) Enhanced gene expression in lung by a stabilized lipoplex using sodium chloride for complex formation. J Gene Med 7:1526-1533.
16. Kawakami S, Sato A, Nishikawa M, Yamashita F, and Hashida M (2000) Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 7:292-299.
17. Kawakami S, Sato A, Yamada M, Yamashita F, and Hashida M (2001) The effect of lipid composition on receptor-mediated in vivo gene transfection using mannosylated cationic liposomes in mice. STP Pharma Sci 11:117-120.
18. Kawakami S, Yamashita F, Nishida K, Nakamura J, and Hashida M (2002) Glycosylated cationic liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 19:171-190.
19. Kuzmin AI, Finegold MJ, and Eisensmith RC (1997) Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther 4:309-316.
20. Lee RJ and Huang L (1997) Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst 14:173-206.
21. Lee YC, Stowell CP, and Krantz MJ (1976) 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins. Biochemistry 15:3956-3963.
22. Li S, Tseng WC, Stolz DB, Wu SP, Watkins SC, and Huang L (1999) Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 6:585-594.
23. Maloy KJ, Erdmann I, Basch V, Sierro S, Kramps TA, Zinkernagel RM, Oehen S, and Kundig TM (2001) Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci USA 98:3299-3303.
24. Madhusudan S, Tamir A, Bates N, Flanagan E, Gore ME, Barton DP, Harper P, Seckl M, Thomas H, Lemoine NR, et al. (2004) A multicenter phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. Clin Cancer Res 10:2986-2996.
25. + T cells. Infect Immun 72:2081-2087.
26. Naito M, Umeda S, Yamamoto T, Moriyama H, Umezu H, Hasegawa G, Usuda H, Shultz LD, and Takahashi K (1996) Development, differentiation and phenotypic heterogeneity of murine tissue macrophages. J Leukoc Biol 59:133-138.
27. Neu M, Fischer D, and Kissel T (2005) Recent advances in rational gene transfer vector design based on poly(ethyleneimine) and its derivatives. J Gene Med 7:992-1009.
28. Philip R, Liggitt D, Philip M, Dazin P, and Debs R (1993) In vivo gene delivery: efficient transfection of T lymphocytes in adult mice. J Biol Chem 268:16087-16090.
29. + T cells after gene gun immunization. J Exp Med 188:1075-1082.
30. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, and Batshaw ML (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:48-58.
31. Sabbatini P, Aghajanian C, Leitao M, Venkatraman E, Anderson S, Dupont J, Dizon D, O'Flaherty C, Bloss J, Chi D, et al. (2004) Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial. Clin Cancer Res 10:2962-2967.
32. Sakurai F, Nishioka T, Saito H, Baba T, Okuda A, Matsumoto O, Taga T, Yamashita F, Takakura Y, and Hashida M (2001) Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Ther 8:677-686.
33. Stellato TA (1992) History of laparoscopic surgery. Surg Clin North Am 72:997-1002.
34. Yamada M, Nishikawa M, Kawakami S, Hattori Y, Nakano T, Yamashita F, and Hashida M (2004) Tissue and intrahepatic distribution and subcellular localization of a mannosylated lipoplex after intravenous administration in mice. J Control Release 98:157-167.
35. Van Rooijen N, Bakker J, and Sanders A (1997) Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol 15:178-185.
36. Van Rooijen N and Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174:8-93.
37. Van Rooijen N and Van Kesteren-Hendrikx E (2002) Clodronate liposomes: perspectives in research and therapeutics. J Liposome Res 12:81-94.